BAYRY Return on Equity (ROE) Analysis

BAYRY's Return on Equity (ROE) of -6.9% means the company is losing money relative to the equity shareholders have invested — for every $100 of equity, it generated a $6.90 loss.

This sits well below the healthcare sector median of 8.9%, placing BAYRY in the 31st percentile among its peers. The year-over-year change is not available, but the quarter-over-quarter change shows improvement of +48.5%, moving from -13.4% to the current -6.9%. The combination of a deeply negative ROE with a recent upward trend suggests the company is still destroying shareholder value, though the pace of losses is narrowing — presenting both ongoing risk and a potential turnaround case if the improvement continues. This metric directly supports the overall CAUTIOUS verdict; a negative ROE far below the sector median indicates weak profitability and high investment risk.

Frequently Asked Questions